Cooper C. Collins

CIK 1485508 · Chief Strategic Officer · last filed 2025-11-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$133.1K

Companies

2

Total Filings

37

Lifetime Open-Market Net

-$19.73M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TXMD Director 60,516 $2.20 $133.1K -$2.99M 24 2025-11-05
PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Chief Strategic Officer 2,980,727 -$16.74M 12 2014-03-05

Recent Filings · Page 4 of 4

37 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2013-10-03 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Sell (S) −66,636 -$169.7K EDGAR
2013-07-25 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Other (J) −1,250,000 -$5.05M EDGAR
2013-06-17 TXMD Sell (S) −2,631,579 -$4.61M EDGAR
2013-05-03 TXMD Grant (A) $0 EDGAR
2012-04-17 Grant (A) $0
2011-07-25 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Sell (S) −498,429 -$3.49M EDGAR
2010-03-11 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Grant (A) +9,405,000 $0 EDGAR
Showing 3137 of 37
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.